Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.397,87
0,09%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Neuronetics Inc (STIM) Neuronetics Inc (STIM) Notizie

Neuronetics Inc

STIM
2,24
0,21 (10,34%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202412:05EDGAR2Form 8-K - Current report
06/6/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:00EDGAR2Form 8-K - Current report
30/5/202422:01EDGAR2Form SD - Specialized disclosure report
23/5/202414:30GLOBENeuronetics to Present at the William Blair 44th Annual..
15/5/202413:32GLOBEHumana Is First Commercial Payer to Address TMS Therapy..
07/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:31EDGAR2Form 8-K - Current report
07/5/202413:30EDGAR2Form 8-K - Current report
07/5/202413:30GLOBENeuronetics Reports Record First Quarter 2024 Financial and..
03/5/202422:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
01/5/202414:31GLOBENeuroStar® TMS Advances Treatment for Adolescents During..
23/4/202422:30GLOBENeuronetics to Report First Quarter 2024 Financial and..
10/4/202414:31GLOBENew Publication in Brain Stimulation Confirms Full TMS..
27/3/202421:30GLOBENeuronetics Reports Inducement Grant Under Nasdaq Listing..
25/3/202413:30GLOBENeuroStar® Advanced Therapy Receives FDA Clearance as a..
07/3/202414:22GLOBENeuronetics Announces 5-Year Exclusive Partnership with..
06/3/202422:01EDGAR2Form 8-K - Current report
05/3/202413:31EDGAR2Form 8-K - Current report
05/3/202413:30EDGAR2Form 8-K - Current report
05/3/202413:30GLOBENeuronetics Reports Record Fourth Quarter and Record Full..
01/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:10EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:48EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:16EDGAR2Form 144 - Report of proposed sale of securities
27/2/202423:33EDGAR2Form 144 - Report of proposed sale of securities
26/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:54EDGAR2Form 144 - Report of proposed sale of securities
23/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:14EDGAR2Form 144 - Report of proposed sale of securities
20/2/202421:19EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:30GLOBENeuronetics to Report Fourth Quarter 2023 Financial and..
16/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:35EDGAR2Form 144 - Report of proposed sale of securities
14/2/202417:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202414:32GLOBENeuronetics Launches Latest Evolution in its TrakStar®..
09/2/202421:39EDGAR2Form 144 - Report of proposed sale of securities
08/2/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:44EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:24EDGAR2Form 144 - Report of proposed sale of securities
06/2/202414:28GLOBENeuroStar TMS Patient Access Expands Through Lucet Health..
Apertura: 2,12 Min: 2,11 Max: 2,28
Chiusura: 2,03

La tua Cronologia

NASDAQ
STIM
Neuronetics
NASDAQ
PLMR
Palomar
BIT
UB5UKK
Unicredit Bank
HUOB
NPXSETH
Pundi X Token
COIN
NAMIETH
Tsunami
LSE
0JDK
Iovance Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network